HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

neoglucobrassicin

structure in first source

Also Known As:

nGBS cpd

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Blaut, Michael: 1 article (09/2015)
2.	Budnowski, Julia: 1 article (09/2015)
3.	Glatt, Hansruedi: 1 article (09/2015)
4.	Hanske, Laura: 1 article (09/2015)
5.	Platz, Stefanie: 1 article (09/2015)
6.	Rohn, Sascha: 1 article (09/2015)
7.	Schumacher, Fabian: 1 article (09/2015)
8.	Andreasson, E: 1 article (09/2001)
9.	Dixelius, C: 1 article (09/2001)
10.	Granér, G: 1 article (09/2001)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2022 - "Glucobrassicin, glucoraphanin and neoglucobrassicin were found mostly concentrated in Band 1. BDVs affected the metabolic activity of different cancer cell lines in a dose dependent manner compared with untreated cells. "
2.	Infections 09/01/2001 - "The glucosinolate levels were also similar, with the exception of glucobrassicin and neoglucobrassicin, which were significantly lower in the resistant cultivar at 11 days post-infection. "
3.	Body Weight (Weight, Body) 09/30/2015 - "Glucoraphanin (172 mg/kg body weight) and neoglucobrassicin (297 mg/kg body weight) were administered intragastrically to germ free and human microbiota associated (HMA) mice. "
4.	COVID-19 01/01/2023 - "Aloin, Genistein, Neoglucobrassicin, and Rutin are our new pipeline candidates for inhibiting PPIs involved in COVID-19. "

Related Drugs and Biologics

1.	glucoraphanin
2.	glucobrassicin
3.	Genistein
4.	Rutin (Rutoside)
5.	Glucosinolates
6.	alloin